Anita Bhat, MD
Endocrinology · Concord
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 3 carriers
- Offices
- 11
- Since medical school
- 21 years
- Graduated 2005
Offices
11 locations · Jiva Health Inc · 46 clinicians in this group
Looking this up.
Hospitals listed: Contra Costa Regional Medical Center · John Muir Medical Center - Concord Campus · John Muir Medical Center - Walnut Creek Campus · Northbay Medical Center. That is not proof they admit you there this week.
Plans that list them
16 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bhat’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A103188 · Current
Licensed to practise in California · since 2008 · expires 2027-10-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Contra Costa Regional Medical CenterMartinez, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Contra Costa Health ServicesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.167, Oct 2024 – Sep 2025
- John Muir Medical Center - Concord CampusConcord, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.235, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.675, Oct 2024 – Sep 2025
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
- Northbay Medical CenterFairfield, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Northbay Healthcare, which runs 2 hospitalsPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.6 (11 to 18.8) · 166 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Contra Costa Regional Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 1 better, 4 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.167 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.04) · 188 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.63 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.8 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 27 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 321 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 1,181 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,198 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.2 (0.67 to 5.72) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 71 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 195 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.36 (1.01 to 19.71) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.08) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.58) · 67 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.93 (0 to 2.03) · 981 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.948 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 2.027 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 101 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 52.2 · 126 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -53.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 87 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.6) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (8.8 to 17.8) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 35 cases | None | Jul 2023 – Jun 2025 |
What patients said (521 patients answered, 10% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for John Muir Medical Center - Concord Campus
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.675 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.21 to 2) · 1,612 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.77 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.13 (136.65 to 231.6) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 537 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,208 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.13 to 0.51) · 7,626 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.29 to 4.91) · 2,723 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.21 (0 to 2.51) · 1,208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.7 to 4.3) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (3.24 to 12.3) · 1,216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.43 (0.43 to 6.43) · 1,253 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.47 to 3.4) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.58 to 1.69) · 6,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 263 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.254 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 768 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.8 · 295 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.1 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.1 · 433 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 504 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.1 to 8.8) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.5 to 15.7) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.8 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 546 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Northbay Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.6 (11 to 18.8) · 166 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.08 (0.1 to 2.06) · 1,001 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.7 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 180.67 (132.84 to 228.51) · 88 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.7 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13 · 180 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 338 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 552 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.6 · 238 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 2,034 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.42) · 6,385 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.02 (1.87 to 6.16) · 1,179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.89 (0.26 to 3.51) · 280 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.02 (0.51 to 3.54) · 1,156 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.55 (4.71 to 20.39) · 284 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (1.99 to 9.92) · 276 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.96 (0.48 to 3.43) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1) · 4,549 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 25 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.663 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.985 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.763 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.923 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 420 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.7 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.6 · 439 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25 · 627 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 560 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.7 to 7.9) · 166 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.9 · 210 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.1 (10.5 to 19) · 196 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 250 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,123 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$1,243,945
Medicare paid this office $1,243,945 for 1,587 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, romosozumab-aqqg, 1 mg | 43 | $313,295 | None |
| Return visit (30+ min) | 1,012 | $243,426 | $97 |
| Injection, denosumab, 1 mg | 112 | $207,977 | None |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 318 | $114,976 | $59 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 219 | $71,412 | $51 |
See all 26 services
| Injection, romosozumab-aqqg, 1 mg | 43 | $313,295 | None |
| Return visit (30+ min) | 1,012 | $243,426 | $97 |
| Injection, denosumab, 1 mg | 112 | $207,977 | None |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 318 | $114,976 | $59 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 219 | $71,412 | $51 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 220 | $69,032 | $47 |
| Short return visit (20+ min) | 686 | $66,653 | $61 |
| New patient visit (45+ min) | 182 | $21,047 | $116 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 214 | $19,681 | $29 |
| New patient visit (30+ min) | 196 | $14,755 | $75 |
| Ultrasound scan of head and neck soft tissue | 108 | $12,871 | $94 |
| Long return visit (40+ min) | 64 | $11,880 | $141 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 66 | $10,210 | $155 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 384 | $8,230 | $14 |
| Injection of drug or substance under skin or into muscle | 168 | $7,495 | $13 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 42 | $6,483 | $154 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $5,786 | $132 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 52 | $5,470 | $38 |
| Transitional care management services for problem of high complexity | 14 | $3,079 | $220 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 47 | $2,970 | $46 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 15 | $1,873 | $125 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 71 | $1,487 | $21 |
| Administration of influenza virus vaccine | 16 | $550 | $34 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 11 | $241 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $147 | $13 |
| Hemoglobin a1c level | 11 | $105 | $10 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 15 | – | – | 12 | 17 | 15 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,587 Original Medicare patients in 2024. Average age 71 · Under 65 15% · 85 and older 8% · Women 67% · Also on Medicaid 35% · Health risk score 1.45. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 50% · Chronic kidney disease 32% · Depression 23% · Coronary heart disease 21% · Heart failure 15% · COPD 15% · Atrial fibrillation 15% · Cancer 11% · Stroke 8% · Dementia 6%.
The office billed $3,136,718, Medicare allowed $1,615,289 and paid $1,243,945; for 68,547 services of 54 kinds; $539,796 of it was for drugs given in the office and $704,149 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,587 | 68,547 | 71 | 1.45 | $3,136,718 | $1,243,945 |
| 2023 | 1,355 | 44,309 | 71 | 1.38 | $2,489,296 | $950,035 |
| 2022 | 1,109 | 19,974 | 71 | 1.35 | $1,552,243 | $565,178 |
| 2021 | 725 | 12,149 | 70 | 1.28 | $901,024 | $380,514 |
| 2020 | 504 | 5,168 | 70 | 1.38 | $536,529 | $211,501 |
| 2019 | 564 | 2,301 | 69 | 1.43 | $407,157 | $173,502 |
| 2018 | 393 | 1,562 | 69 | 1.34 | $310,813 | $128,365 |
| 2017 | 279 | 1,012 | 69 | 1.60 | $179,273 | $74,411 |
| 2016 | 306 | 1,284 | 68 | 1.50 | $224,799 | $107,469 |
| 2015 | 257 | 1,279 | 68 | 1.27 | $194,830 | $106,069 |
| 2014 | 228 | 1,075 | 67 | 1.42 | $147,095 | $88,115 |
| 2013 | 189 | 988 | 67 | 1.49 | $132,235 | $81,792 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 27 services
| Return visit (30+ min) | 870 | $208,802 | $96 |
| Injection, denosumab, 1 mg | 111 | $182,488 | None |
| Injection, romosozumab-aqqg, 1 mg | 16 | $148,482 | None |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 222 | $79,638 | $59 |
| Short return visit (20+ min) | 702 | $79,524 | $64 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 183 | $50,709 | $47 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 179 | $49,554 | $54 |
| New patient visit (45+ min) | 167 | $20,645 | $124 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 108 | $16,582 | $154 |
| Long return visit (40+ min) | 95 | $15,777 | $137 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 203 | $15,286 | $29 |
| New patient visit (30+ min) | 197 | $14,963 | $76 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 90 | $13,786 | $147 |
| Ultrasound scan of head and neck soft tissue | 108 | $13,518 | $103 |
| Injection of drug or substance under skin or into muscle | 151 | $5,538 | $13 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 23 | $4,460 | $127 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 56 | $3,761 | $38 |
| New patient visit (60+ min) | 18 | $3,455 | $192 |
| Transitional care management services for problem of high complexity | 13 | $2,964 | $212 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 51 | $2,818 | $45 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 16 | $2,210 | $130 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 85 | $1,718 | $20 |
| Administration of influenza virus vaccine | 41 | $1,438 | $35 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 37 | $788 | $21 |
| Annual depression screening, 5 to 15 minutes | 25 | $572 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | $282 | $12 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 14 | $30 | None |
2022: 26 services
| Return visit (30+ min) | 715 | $137,864 | $97 |
| Injection, denosumab, 1 mg | 80 | $118,767 | None |
| Short return visit (20+ min) | 488 | $54,966 | $68 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 113 | $31,681 | $55 |
| New patient visit (45+ min) | 229 | $31,018 | $135 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 117 | $30,844 | $46 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 101 | $25,543 | $58 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 75 | $11,033 | $147 |
| Ultrasound scan of head and neck soft tissue | 83 | $10,515 | $111 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 187 | $9,153 | $30 |
| Long return visit (40+ min) | 58 | $9,104 | $136 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 52 | $7,896 | $152 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 75 | $6,293 | $37 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 36 | $6,009 | $125 |
| New patient visit (30+ min) | 68 | $5,796 | $85 |
| New patient visit (60+ min) | 27 | $5,054 | $187 |
| Injection of drug or substance under skin or into muscle | 100 | $3,401 | $13 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 35 | $2,144 | $44 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 11 | $1,594 | $133 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 75 | $1,478 | $19 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 17 | $1,190 | $70 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 18 | $1,068 | $51 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $783 | $65 |
| Administration of influenza virus vaccine | 22 | $773 | $35 |
| Hemoglobin a1c level, by device for home use | 23 | $230 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $148 | $12 |
2021: 20 services
| Return visit (30+ min) | 455 | $118,168 | $112 |
| Injection, denosumab, 1 mg | 53 | $74,390 | None |
| Short return visit (20+ min) | 419 | $64,693 | $80 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 65 | $15,729 | $60 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 66 | $13,311 | $45 |
| New patient visit (45+ min) | 79 | $11,797 | $149 |
| Long return visit (40+ min) | 52 | $10,192 | $154 |
| Ultrasound scan of head and neck soft tissue | 70 | $9,867 | $115 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 34 | $5,724 | $159 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 77 | $4,901 | $31 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $4,561 | $157 |
| Injection of drug or substance under skin or into muscle | 68 | $2,499 | $13 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 31 | $2,196 | $35 |
| New patient visit (30+ min) | 13 | $1,064 | $82 |
| Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preve | 14 | $1,041 | $74 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 14 | $770 | $51 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 36 | $708 | $19 |
| Administration of influenza virus vaccine | 19 | $400 | $21 |
| Hemoglobin a1c level, by device for home use | 15 | $165 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $149 | $14 |
2020: 20 services
| Return visit (30+ min) | 343 | $76,301 | $89 |
| Injection, denosumab, 1 mg | 38 | $45,335 | None |
| Short return visit (20+ min) | 276 | $34,060 | $65 |
| Ultrasound scan of head and neck soft tissue | 59 | $9,040 | $116 |
| New patient visit (45+ min) | 61 | $6,540 | $107 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 30 | $6,077 | $203 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 28 | $4,856 | $66 |
| Long return visit (40+ min) | 33 | $4,316 | $120 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 27 | $3,620 | $50 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $3,498 | $140 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 21 | $3,373 | $153 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 44 | $2,577 | $31 |
| Injection of drug or substance under skin or into muscle | 48 | $1,897 | $13 |
| Influenza vaccine, inactivated | 29 | $1,781 | $59 |
| New patient visit (30+ min) | 18 | $1,097 | $61 |
| Administration of influenza virus vaccine | 34 | $738 | $21 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 29 | $576 | $20 |
| Photography of the retina | 13 | $517 | $40 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 12 | $214 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $184 | $17 |
2019: 15 services
| Return visit (30+ min) | 366 | $78,394 | $89 |
| Short return visit (20+ min) | 253 | $33,095 | $64 |
| New patient visit (45+ min) | 114 | $15,726 | $138 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 52 | $8,125 | $153 |
| Ultrasound scan of head and neck soft tissue | 61 | $8,125 | $108 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 31 | $6,221 | $201 |
| Long return visit (40+ min) | 36 | $5,141 | $120 |
| New patient visit (30+ min) | 37 | $3,619 | $98 |
| Influenza vaccine, inactivated | 40 | $2,324 | $58 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 58 | $2,213 | $31 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 14 | $1,811 | $121 |
| Injection of drug or substance under skin or into muscle | 31 | $1,134 | $16 |
| Administration of influenza virus vaccine | 51 | $1,049 | $20 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 13 | $358 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $261 | $16 |
2018: 12 services
| Return visit (30+ min) | 281 | $65,791 | $89 |
| Short return visit (20+ min) | 171 | $23,227 | $62 |
| New patient visit (45+ min) | 122 | $14,000 | $115 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 49 | $7,567 | $151 |
| Ultrasound scan of head and neck soft tissue | 39 | $5,083 | $111 |
| Long return visit (40+ min) | 27 | $3,273 | $121 |
| Fine needle aspiration using imaging guidance | 11 | $1,823 | $130 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 46 | $1,530 | $31 |
| Influenza vaccine, inactivated | 16 | $800 | $50 |
| Administration of influenza virus vaccine | 25 | $632 | $25 |
| Injection of drug or substance under skin or into muscle | 16 | $628 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $173 | $16 |
2017: 8 services
| Return visit (30+ min) | 169 | $32,990 | $85 |
| Short return visit (20+ min) | 184 | $24,479 | $58 |
| New patient visit (45+ min) | 53 | $6,276 | $118 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 28 | $4,325 | $149 |
| Ultrasound scan of head and neck soft tissue | 20 | $2,129 | $101 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 24 | $814 | $33 |
| Administration of influenza virus vaccine | 12 | $373 | $31 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 12 | $223 | $19 |
2016: 8 services
| Return visit (30+ min) | 223 | $59,144 | $90 |
| Short return visit (20+ min) | 130 | $18,231 | $60 |
| New patient visit (45+ min) | 104 | $13,721 | $132 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 55 | $9,604 | $155 |
| Ultrasound scan of head and neck soft tissue | 20 | $2,318 | $110 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 46 | $1,695 | $36 |
| Administration of influenza virus vaccine | 31 | $957 | $30 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 32 | $532 | $16 |
2015: 8 services
| Return visit (30+ min) | 213 | $64,302 | $92 |
| Short return visit (20+ min) | 75 | $14,573 | $60 |
| New patient visit (45+ min) | 94 | $12,512 | $133 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 43 | $7,256 | $154 |
| Ultrasound scan of head and neck soft tissue | 18 | $2,000 | $111 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 39 | $1,521 | $37 |
| Administration of influenza virus vaccine | 34 | $1,021 | $30 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 36 | $490 | $14 |
2014: 8 services
| Return visit (30+ min) | 188 | $58,810 | $90 |
| New patient visit (45+ min) | 89 | $11,951 | $134 |
| Short return visit (20+ min) | 54 | $8,432 | $62 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 21 | $3,488 | $152 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 28 | $1,409 | $36 |
| Injection of drug or substance under skin or into muscle | 13 | $762 | $23 |
| Administration of influenza virus vaccine | 23 | $675 | $29 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 23 | $315 | $14 |
2013: 7 services
| Return visit (30+ min) | 136 | $40,435 | $93 |
| New patient visit (45+ min) | 137 | $18,795 | $137 |
| Short return visit (20+ min) | 77 | $13,558 | $63 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 16 | $2,787 | $164 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 12 | $807 | $37 |
| Administration of influenza virus vaccine | 13 | $320 | $25 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 14 | $171 | $12 |
Medicaid work
$659,014 in 2024
Medicaid paid $659,014 for 9,937 billed services this clinician did in 2024, up to 255 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 2,332 | $190,774 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 1,622 | $104,183 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 1,290 | $93,127 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 1,272 | $72,645 |
| Short return visit (20+ min) | 1,090 | $58,985 |
| New patient visit (45+ min) | 381 | $52,061 |
| New patient visit (30+ min) | 355 | $34,914 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report | 621 | $29,989 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 86 | $7,695 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 410 | $5,266 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; set-up and patient education on use of equipment | 88 | $2,308 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 155 | $2,290 |
| 2024 | 9,937 | 15 | 255 | $659,014 |
| 2023 | 6,721 | 15 | 179 | $391,266 |
| 2022 | 1,610 | 8 | 117 | $127,051 |
| 2021 | 940 | 4 | 54 | $105,550 |
| 2020 | 837 | 2 | 50 | $72,757 |
| 2019 | 754 | 3 | 55 | $73,435 |
| 2018 | 645 | 3 | 45 | $67,695 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 1,813 | $131,587 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 1,047 | $51,498 |
| Short return visit (20+ min) | 1,008 | $51,275 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 781 | $45,257 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 811 | $35,736 |
| New patient visit (30+ min) | 329 | $29,859 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report | 451 | $18,729 |
| New patient visit (45+ min) | 126 | $14,124 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 62 | $5,483 |
| Long return visit (40+ min) | 19 | $2,794 |
| Other procedure on endocrine system | 173 | $2,173 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; each additional 20 minutes (List separately in addition to code for primary procedure) | 26 | $1,196 |
2022
| Return visit (30+ min) | 756 | $71,693 |
| Short return visit (20+ min) | 325 | $26,233 |
| New patient visit (45+ min) | 89 | $10,167 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 131 | $6,311 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 112 | $5,287 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 133 | $5,028 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report | 44 | $2,121 |
| Other procedure on endocrine system | 20 | $211 |
2021
| Return visit (30+ min) | 456 | $58,461 |
| Short return visit (20+ min) | 443 | $40,498 |
| New patient visit (45+ min) | 28 | $4,781 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 13 | $1,810 |
2020
| Return visit (30+ min) | 539 | $52,164 |
| Short return visit (20+ min) | 298 | $20,593 |
2019
| Return visit (30+ min) | 458 | $50,028 |
| Short return visit (20+ min) | 283 | $21,472 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 13 | $1,935 |
2018
| Return visit (30+ min) | 382 | $41,437 |
| Short return visit (20+ min) | 201 | $15,615 |
| New patient visit (45+ min) | 62 | $10,642 |
Drugs they prescribed that Part D paid
$800,700
Pharmacies billed $800,700 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
879 generic and 703 brand-name prescriptions · $800,700 in drug cost · 11 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 78 | $108,273 | $1,388 |
| Mounjaro | 63 | $96,597 | $1,533 |
| Ozempic | 38 | $85,203 | $2,242 |
| Forteo | 13 | $64,725 | $4,979 |
| Tymlos | 15 | $53,479 | $3,565 |
See all 30 drugs
| Jardiance | 78 | $108,273 | $1,388 |
| Mounjaro | 63 | $96,597 | $1,533 |
| Ozempic | 38 | $85,203 | $2,242 |
| Forteo | 13 | $64,725 | $4,979 |
| Tymlos | 15 | $53,479 | $3,565 |
| Trulicity | 25 | $43,720 | $1,749 |
| Synjardy Xr | 14 | $23,047 | $1,646 |
| Kerendia | 13 | $20,970 | $1,613 |
| Farxiga | 17 | $15,435 | $908 |
| Shingrix | 29 | $6,455 | $223 |
| Basaglar Kwikpen U-100 | 11 | $5,037 | $458 |
| Lantus Solostar | 36 | $4,751 | $132 |
| Synthroid | 41 | $4,103 | $100 |
| Rosuvastatin | 78 | $1,804 | $23 |
| Levothyroxine | 124 | $1,268 | $10 |
| Metformin Hcl Er | 60 | $1,099 | $18 |
| Ultra-Fine Short Pen Needle | 17 | $997 | $59 |
| Liothyronine | 17 | $984 | $58 |
| Adacel Tdap | 12 | $842 | $70 |
| Atorvastatin | 70 | $676 | $10 |
| Albuterol Sulfate Hfa | 17 | $508 | $30 |
| Hydralazine | 13 | $411 | $32 |
| Carvedilol | 16 | $283 | $18 |
| Methimazole | 23 | $223 | $10 |
| Losartan | 23 | $209 | $9 |
| Metformin | 25 | $206 | $8 |
| Amlodipine Besylate | 35 | $194 | $6 |
| Pioglitazone | 15 | $180 | $12 |
| Lisinopril | 31 | $144 | $5 |
| Spironolactone | 13 | $127 | $10 |
Year by year
| 2024 | 1,651 | 407 | None | 43% | $800,700 |
| 2023 | 1,228 | 344 | None | 45% | $840,987 |
| 2022 | 1,380 | 424 | None | 41% | $754,112 |
| 2021 | 2,023 | 431 | 1% (13) | 34% | $771,232 |
| 2020 | 3,989 | 505 | 2% (61) | 33% | $1,118,902 |
| 2019 | 3,796 | 522 | 2% (60) | 33% | $1,076,115 |
| 2018 | 4,816 | 492 | 2% (87) | 30% | $1,103,536 |
| 2017 | 4,761 | 394 | 2% (102) | 28% | $850,153 |
| 2016 | 4,209 | 356 | 2% (95) | 29% | $671,968 |
| 2015 | 3,471 | 290 | 3% (110) | 28% | $454,526 |
| 2014 | 2,758 | 291 | 3% (92) | 29% | $308,064 |
| 2013 | 1,785 | 251 | 2% (43) | 33% | $181,914 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Trulicity | 52 | $104,377 | $2,007 |
| Jardiance | 57 | $82,096 | $1,440 |
| Ozempic | 37 | $68,973 | $1,864 |
| Forteo | 12 | $55,865 | $4,655 |
| Humalog Kwikpen U-200 | 13 | $49,998 | $3,846 |
| Kerendia | 22 | $38,725 | $1,760 |
| Mounjaro | 21 | $34,872 | $1,661 |
| Novolog | 17 | $31,500 | $1,853 |
| Farxiga | 18 | $30,331 | $1,685 |
| Rybelsus | 13 | $26,168 | $2,013 |
| Novolog Flexpen | 22 | $20,998 | $954 |
| Lantus Solostar | 18 | $19,771 | $1,098 |
| Humalog Kwikpen U-100 | 12 | $19,141 | $1,595 |
| Synjardy Xr | 11 | $18,398 | $1,673 |
| Basaglar Kwikpen U-100 | 15 | $5,867 | $391 |
| Synthroid | 31 | $3,126 | $101 |
| Rosuvastatin | 31 | $1,496 | $48 |
| Levothyroxine | 93 | $1,359 | $15 |
| Metformin Hcl Er | 55 | $1,036 | $19 |
| Nano 2nd Gen Pen Needle | 11 | $938 | $85 |
| Atorvastatin | 60 | $937 | $16 |
| Liothyronine | 18 | $921 | $51 |
| Losartan | 55 | $881 | $16 |
| Ultra-Fine Short Pen Needle | 12 | $639 | $53 |
| Methimazole | 15 | $447 | $30 |
| Pioglitazone | 19 | $398 | $21 |
| Amlodipine Besylate | 30 | $341 | $11 |
| Lisinopril | 25 | $269 | $11 |
| Metformin | 13 | $206 | $16 |
| Glipizide | 11 | $150 | $14 |
2022: 32 drugs
| Trulicity | 77 | $151,437 | $1,967 |
| Jardiance | 39 | $51,913 | $1,331 |
| Ozempic | 35 | $48,934 | $1,398 |
| Humalog Kwikpen U-100 | 22 | $39,113 | $1,778 |
| Lantus Solostar | 39 | $31,260 | $802 |
| Novolog | 13 | $25,887 | $1,991 |
| Farxiga | 17 | $25,107 | $1,477 |
| Omnipod Dash Pods (Gen 4) | 15 | $24,272 | $1,618 |
| Januvia | 18 | $22,549 | $1,253 |
| Novolog Flexpen | 12 | $15,594 | $1,299 |
| Humalog Kwikpen U-200 | 13 | $14,146 | $1,088 |
| Synthroid | 32 | $3,480 | $109 |
| Levothyroxine | 102 | $2,166 | $21 |
| Nano 2nd Gen Pen Needle | 18 | $2,070 | $115 |
| Ultra-Fine Short Pen Needle | 14 | $1,307 | $93 |
| Atorvastatin | 57 | $1,045 | $18 |
| Liothyronine | 16 | $1,015 | $63 |
| Droplet Pen Needle | 11 | $780 | $71 |
| Metformin Hcl Er | 62 | $698 | $11 |
| Losartan | 57 | $522 | $9 |
| Pioglitazone | 16 | $456 | $29 |
| Escitalopram | 13 | $388 | $30 |
| Amlodipine Besylate | 55 | $319 | $6 |
| Metformin | 31 | $315 | $10 |
| Rosuvastatin | 19 | $284 | $15 |
| Lovastatin | 15 | $172 | $11 |
| Glipizide | 12 | $144 | $12 |
| Simvastatin | 13 | $143 | $11 |
| Metoprolol | 13 | $127 | $10 |
| Lisinopril | 18 | $122 | $7 |
| Atenolol | 15 | $96 | $6 |
| Hydrochlorothiazide | 12 | $69 | $6 |
2021: 48 drugs
| Trulicity | 81 | $134,753 | $1,664 |
| Jardiance | 41 | $59,527 | $1,452 |
| Omnipod Dash | 20 | $38,417 | $1,921 |
| Humalog Kwikpen U-100 | 21 | $35,496 | $1,690 |
| Tymlos | 16 | $35,161 | $2,198 |
| Ozempic | 22 | $31,332 | $1,424 |
| Novolog | 17 | $27,785 | $1,634 |
| Lantus Solostar | 47 | $27,521 | $586 |
| Victoza 3-Pak | 15 | $19,099 | $1,273 |
| Tresiba Flextouch U-200 | 20 | $17,200 | $860 |
| Levemir Flextouch | 12 | $14,788 | $1,232 |
| Novolog Flexpen | 16 | $13,357 | $835 |
| Repatha Sureclick | 16 | $13,167 | $823 |
| Insulin Lispro Kwikpen U-100 | 20 | $12,798 | $640 |
| Apidra | 14 | $7,281 | $520 |
| Tresiba Flextouch U-100 | 16 | $7,095 | $443 |
| Testosterone | 18 | $4,132 | $230 |
| Levemir | 12 | $3,908 | $326 |
| Levothyroxine | 141 | $3,035 | $22 |
| Liothyronine | 31 | $2,722 | $88 |
| Synthroid | 21 | $2,664 | $127 |
| Metformin Hcl Er | 72 | $1,536 | $21 |
| Atorvastatin | 127 | $1,507 | $12 |
| Ultra-Fine Mini Pen Needle | 12 | $1,240 | $103 |
| Rosuvastatin | 13 | $989 | $76 |
| Ultra-Fine Short Pen Needle | 11 | $825 | $75 |
| Hydrocortisone | 12 | $796 | $66 |
| Albuterol Sulfate Hfa | 12 | $737 | $61 |
| Losartan | 53 | $574 | $11 |
| Lisinopril | 69 | $556 | $8 |
| Testosterone Cypionate | 12 | $521 | $43 |
| Metformin | 67 | $518 | $8 |
| Gabapentin | 33 | $497 | $15 |
| Amlodipine Besylate | 81 | $491 | $6 |
| Venlafaxine Hcl Er | 12 | $428 | $36 |
| Metoprolol | 16 | $366 | $23 |
| Omeprazole | 16 | $366 | $23 |
| Hydrochlorothiazide | 35 | $329 | $9 |
| Pioglitazone | 18 | $329 | $18 |
| Pantoprazole | 13 | $303 | $23 |
| Methimazole | 14 | $217 | $15 |
| Triamterene-Hydrochlorothiazid | 15 | $202 | $13 |
| Hydralazine | 14 | $200 | $14 |
| Atenolol | 20 | $172 | $9 |
| Simvastatin | 24 | $165 | $7 |
| Tamsulosin | 11 | $126 | $11 |
| Glipizide | 12 | $108 | $9 |
| Furosemide | 12 | $75 | $6 |
2020: 89 drugs
| Trulicity | 93 | $143,178 | $1,540 |
| Tymlos | 40 | $82,787 | $2,070 |
| Jardiance | 55 | $66,343 | $1,206 |
| Humalog Kwikpen U-100 | 49 | $50,356 | $1,028 |
| Humalog | 35 | $47,833 | $1,367 |
| Lantus Solostar | 80 | $47,334 | $592 |
| Novolog | 32 | $46,571 | $1,455 |
| Novolog Flexpen | 50 | $45,967 | $919 |
| Victoza 3-Pak | 27 | $42,845 | $1,587 |
| Januvia | 36 | $38,714 | $1,075 |
| Tresiba Flextouch U-200 | 39 | $33,098 | $849 |
| Ozempic | 12 | $25,004 | $2,084 |
| Bydureon Bcise | 17 | $18,630 | $1,096 |
| Tradjenta | 14 | $16,660 | $1,190 |
| Lantus | 22 | $14,858 | $675 |
| Soliqua 100-33 | 16 | $14,234 | $890 |
| Levemir Flextouch | 17 | $13,807 | $812 |
| Basaglar Kwikpen U-100 | 31 | $10,263 | $331 |
| Eliquis | 16 | $9,934 | $621 |
| Insulin Lispro Kwikpen U-100 | 20 | $9,682 | $484 |
| Toujeo Solostar | 21 | $8,475 | $404 |
| Symbicort | 15 | $7,725 | $515 |
| Testosterone | 24 | $7,431 | $310 |
| Repatha Sureclick | 13 | $7,099 | $546 |
| Levothyroxine | 278 | $6,893 | $25 |
| Synthroid | 70 | $6,647 | $95 |
| Liothyronine | 79 | $6,261 | $79 |
| Xyosted | 11 | $5,661 | $515 |
| Praluent | 11 | $5,074 | $461 |
| Tirosint | 18 | $4,804 | $267 |
| Atorvastatin | 218 | $3,147 | $14 |
| Ultra-Fine Nano Pen Needle | 31 | $2,469 | $80 |
| Ultra-Fine Mini Pen Needle | 23 | $2,363 | $103 |
| Metformin Hcl Er | 125 | $2,206 | $18 |
| Rosuvastatin | 33 | $2,105 | $64 |
| Testosterone Cypionate | 49 | $1,984 | $40 |
| Hydrocortisone | 27 | $1,751 | $65 |
| Gabapentin | 48 | $1,508 | $31 |
| Potassium Chloride | 22 | $1,353 | $61 |
| Lisinopril | 136 | $1,016 | $7 |
| Losartan | 83 | $951 | $11 |
| Fenofibrate | 11 | $890 | $81 |
| Metformin | 104 | $865 | $8 |
| Novofine 32 | 11 | $841 | $76 |
| Hydrocodone-Acetaminophen | 34 | $833 | $25 |
| Amlodipine Besylate | 119 | $801 | $7 |
| Bupropion Xl | 14 | $773 | $55 |
| Desmopressin Acetate | 17 | $755 | $44 |
| Omeprazole | 45 | $701 | $16 |
| Ventolin Hfa | 11 | $687 | $62 |
| Metoprolol | 39 | $674 | $17 |
| Buspirone | 12 | $646 | $54 |
| Pioglitazone | 26 | $545 | $21 |
| Hydrochlorothiazide | 73 | $538 | $7 |
| Trazodone | 30 | $521 | $17 |
| Hydroxychloroquine Sulfate | 13 | $506 | $39 |
| Tamsulosin | 19 | $505 | $27 |
| Venlafaxine Hcl Er | 16 | $455 | $28 |
| Losartan-Hydrochlorothiazide | 16 | $443 | $28 |
| Pantoprazole | 35 | $439 | $13 |
| Diclofenac | 11 | $404 | $37 |
| Montelukast | 26 | $403 | $15 |
| Clonazepam | 41 | $376 | $9 |
| Carvedilol | 34 | $365 | $11 |
| Simvastatin | 41 | $358 | $9 |
| Verapamil Sr | 12 | $354 | $29 |
| Triamterene-Hydrochlorothiazid | 23 | $343 | $15 |
| Lovastatin | 22 | $342 | $16 |
| Alendronate | 23 | $339 | $15 |
| Hydralazine | 22 | $335 | $15 |
| Clopidogrel | 16 | $334 | $21 |
| Methimazole | 19 | $327 | $17 |
| Glimepiride | 15 | $311 | $21 |
| Estradiol | 11 | $297 | $27 |
| Escitalopram | 21 | $272 | $13 |
| Allopurinol | 21 | $264 | $13 |
| Paroxetine | 12 | $259 | $22 |
| Atenolol | 35 | $249 | $7 |
| Glipizide | 22 | $249 | $11 |
| Finasteride | 22 | $247 | $11 |
| Furosemide | 18 | $222 | $12 |
| Valsartan-Hydrochlorothiazide | 13 | $202 | $16 |
| Metoprolol | 21 | $185 | $9 |
| Sertraline | 13 | $160 | $12 |
| Fluticasone Propionate | 11 | $156 | $14 |
| Alprazolam | 17 | $114 | $7 |
| Tramadol | 16 | $94 | $6 |
| Lorazepam | 11 | $62 | $6 |
| Ciprofloxacin | 12 | $45 | $4 |
2019: 78 drugs
| Trulicity | 75 | $105,308 | $1,404 |
| Novolog Flexpen | 88 | $75,882 | $862 |
| Victoza 3-Pak | 42 | $56,385 | $1,343 |
| Humalog Kwikpen U-100 | 68 | $55,358 | $814 |
| Novolog | 55 | $53,828 | $979 |
| Levemir Flextouch | 38 | $50,546 | $1,330 |
| Humalog | 36 | $49,934 | $1,387 |
| Jardiance | 30 | $44,368 | $1,479 |
| Lantus Solostar | 90 | $40,267 | $447 |
| Januvia | 36 | $38,831 | $1,079 |
| Ozempic | 27 | $36,162 | $1,339 |
| Prolia | 24 | $29,784 | $1,241 |
| Tresiba Flextouch U-200 | 21 | $20,756 | $988 |
| Bydureon Bcise | 21 | $19,368 | $922 |
| Janumet | 14 | $17,523 | $1,252 |
| Toujeo Solostar | 18 | $16,422 | $912 |
| Tradjenta | 20 | $15,951 | $798 |
| Tresiba Flextouch U-100 | 19 | $14,402 | $758 |
| Janumet Xr | 11 | $14,010 | $1,274 |
| Lantus | 19 | $13,891 | $731 |
| Testosterone | 19 | $12,279 | $646 |
| Levothyroxine | 296 | $7,282 | $25 |
| Basaglar Kwikpen U-100 | 12 | $6,659 | $555 |
| Bromocriptine Mesylate | 12 | $5,224 | $435 |
| Liothyronine | 70 | $4,676 | $67 |
| Advair Diskus | 12 | $3,973 | $331 |
| Ultra-Fine Nano Pen Needle | 52 | $3,935 | $76 |
| Tirosint | 13 | $3,678 | $283 |
| Atorvastatin | 159 | $2,855 | $18 |
| Synthroid | 33 | $2,807 | $85 |
| Rosuvastatin | 31 | $2,573 | $83 |
| Ultra-Fine Mini Pen Needle | 30 | $2,149 | $72 |
| Hydrocortisone | 24 | $1,983 | $83 |
| Testosterone Cypionate | 35 | $1,840 | $53 |
| Gabapentin | 58 | $1,724 | $30 |
| Metformin Hcl Er | 105 | $1,608 | $15 |
| Metoprolol | 49 | $1,537 | $31 |
| Amlodipine Besylate | 145 | $1,335 | $9 |
| Duloxetine | 27 | $1,259 | $47 |
| Lisinopril | 120 | $1,235 | $10 |
| Metformin | 122 | $1,173 | $10 |
| Estradiol | 21 | $1,042 | $50 |
| Novofine 32 | 15 | $1,025 | $68 |
| Bupropion Xl | 13 | $942 | $72 |
| Losartan | 70 | $942 | $13 |
| Fenofibrate | 18 | $899 | $50 |
| Venlafaxine Hcl Er | 18 | $860 | $48 |
| Hydrocodone-Acetaminophen | 33 | $816 | $25 |
| Potassium Chloride | 21 | $759 | $36 |
| Spironolactone | 25 | $702 | $28 |
| Methimazole | 30 | $615 | $21 |
| Clonazepam | 42 | $604 | $14 |
| Simvastatin | 65 | $549 | $8 |
| Tamsulosin | 31 | $518 | $17 |
| Hydrochlorothiazide | 68 | $511 | $8 |
| Alprazolam | 27 | $453 | $17 |
| Pantoprazole | 27 | $451 | $17 |
| Clopidogrel | 19 | $427 | $22 |
| Ultra-Fine Short Pen Needle | 11 | $426 | $39 |
| Pioglitazone | 23 | $424 | $18 |
| Glipizide | 44 | $417 | $9 |
| Carvedilol | 22 | $377 | $17 |
| Montelukast | 14 | $266 | $19 |
| Omeprazole | 21 | $259 | $12 |
| Furosemide | 21 | $259 | $12 |
| Triamterene-Hydrochlorothiazid | 13 | $245 | $19 |
| Atenolol | 29 | $237 | $8 |
| Trazodone | 15 | $229 | $15 |
| Citalopram Hbr | 14 | $220 | $16 |
| Losartan-Hydrochlorothiazide | 11 | $216 | $20 |
| Alendronate | 14 | $212 | $15 |
| Metoclopramide | 16 | $202 | $13 |
| Tramadol | 23 | $202 | $9 |
| Ibuprofen | 12 | $190 | $16 |
| Fluticasone Propionate | 13 | $144 | $11 |
| Pramipexole Dihydrochloride | 13 | $126 | $10 |
| Zolpidem | 16 | $123 | $8 |
| Lorazepam | 14 | $73 | $5 |
2018: 101 drugs
| Novolog | 67 | $84,288 | $1,258 |
| Novolog Flexpen | 110 | $73,042 | $664 |
| Levemir Flextouch | 51 | $61,524 | $1,206 |
| Lantus Solostar | 110 | $59,408 | $540 |
| Humalog Kwikpen U-100 | 69 | $57,873 | $839 |
| Trulicity | 35 | $52,721 | $1,506 |
| Victoza 3-Pak | 41 | $49,959 | $1,219 |
| Jardiance | 37 | $36,621 | $990 |
| Tresiba Flextouch U-200 | 36 | $32,759 | $910 |
| Humalog | 29 | $32,633 | $1,125 |
| Januvia | 28 | $30,953 | $1,105 |
| Lantus | 44 | $28,159 | $640 |
| Prolia | 21 | $25,081 | $1,194 |
| Tradjenta | 28 | $22,760 | $813 |
| Bydureon Bcise | 20 | $18,708 | $935 |
| Toujeo Solostar | 29 | $16,850 | $581 |
| Androgel | 11 | $13,818 | $1,256 |
| Janumet | 14 | $13,502 | $964 |
| Tresiba Flextouch U-100 | 21 | $13,181 | $628 |
| Victoza 2-Pak | 12 | $11,193 | $933 |
| Levothyroxine | 359 | $9,301 | $26 |
| Eliquis | 18 | $8,815 | $490 |
| Combivent Respimat | 15 | $5,651 | $377 |
| Symbicort | 16 | $5,605 | $350 |
| Ultra-Fine Nano Pen Needle | 65 | $5,077 | $78 |
| Kombiglyze Xr | 11 | $4,718 | $429 |
| Bromocriptine Mesylate | 13 | $4,440 | $342 |
| Dexilant | 15 | $4,161 | $277 |
| Atorvastatin | 185 | $3,289 | $18 |
| Ultra-Fine Mini Pen Needle | 51 | $3,168 | $62 |
| Rosuvastatin | 47 | $3,083 | $66 |
| Liothyronine | 65 | $2,669 | $41 |
| Gabapentin | 98 | $2,148 | $22 |
| Bupropion Xl | 24 | $1,821 | $76 |
| Metoprolol | 46 | $1,758 | $38 |
| Synthroid | 28 | $1,708 | $61 |
| Venlafaxine Hcl Er | 30 | $1,606 | $54 |
| Estradiol | 36 | $1,595 | $44 |
| Metformin | 188 | $1,534 | $8 |
| Tamsulosin | 36 | $1,495 | $42 |
| Ventolin Hfa | 22 | $1,443 | $66 |
| Nifedipine Er | 19 | $1,316 | $69 |
| Hydrocodone-Acetaminophen | 55 | $1,311 | $24 |
| Potassium Chloride | 47 | $1,305 | $28 |
| Metformin Hcl Er | 106 | $1,276 | $12 |
| Amlodipine Besylate | 184 | $1,271 | $7 |
| Testosterone Cypionate | 30 | $1,265 | $42 |
| Lisinopril | 148 | $1,199 | $8 |
| Duloxetine | 17 | $1,198 | $70 |
| Fenofibrate | 16 | $1,052 | $66 |
| Novofine 32 | 16 | $1,047 | $65 |
| Losartan | 80 | $933 | $12 |
| Methimazole | 29 | $915 | $32 |
| Alprazolam | 36 | $903 | $25 |
| Polyethylene Glycol 3350 | 17 | $828 | $49 |
| Pravastatin | 19 | $791 | $42 |
| Hydrocortisone | 17 | $774 | $46 |
| Ultra-Fine Short Pen Needle | 15 | $720 | $48 |
| Clopidogrel | 36 | $702 | $20 |
| Simvastatin | 86 | $700 | $8 |
| Insulin | 18 | $681 | $38 |
| Pantoprazole | 54 | $654 | $12 |
| Pioglitazone | 35 | $604 | $17 |
| Spironolactone | 23 | $554 | $24 |
| Montelukast | 28 | $501 | $18 |
| Carvedilol | 39 | $501 | $13 |
| Glipizide | 49 | $451 | $9 |
| Fluticasone Propionate | 24 | $419 | $17 |
| Hydrochlorothiazide | 71 | $413 | $6 |
| Acyclovir | 17 | $388 | $23 |
| Omeprazole | 26 | $386 | $15 |
| Clonazepam | 25 | $383 | $15 |
| Tramadol | 23 | $382 | $17 |
| Hydroxyzine | 11 | $369 | $34 |
| Furosemide | 39 | $345 | $9 |
| Lisinopril-Hydrochlorothiazide | 36 | $328 | $9 |
| Escitalopram | 18 | $325 | $18 |
| Novolin 70-30 | 11 | $274 | $25 |
| Insulin | 13 | $268 | $21 |
| Losartan-Hydrochlorothiazide | 13 | $263 | $20 |
| Ranitidine | 24 | $251 | $10 |
| Triamterene-Hydrochlorothiazid | 19 | $248 | $13 |
| Atenolol | 39 | $239 | $6 |
| Alendronate | 13 | $218 | $17 |
| Ibuprofen | 16 | $216 | $13 |
| Citalopram Hbr | 22 | $204 | $9 |
| Trazodone | 19 | $198 | $10 |
| Paroxetine | 11 | $168 | $15 |
| Lorazepam | 39 | $161 | $4 |
| Hydralazine | 12 | $158 | $13 |
| Glimepiride | 12 | $155 | $13 |
| Metoprolol | 23 | $155 | $7 |
| Pramipexole Dihydrochloride | 13 | $143 | $11 |
| Fluoxetine | 11 | $138 | $13 |
| Zolpidem | 21 | $129 | $6 |
| Amiloride | 12 | $111 | $9 |
| Famotidine | 12 | $109 | $9 |
| Levocetirizine Dihydrochloride | 15 | $109 | $7 |
| Topiramate | 11 | $93 | $8 |
| Ciprofloxacin | 18 | $84 | $5 |
| Dexamethasone | 11 | $24 | $2 |
2017: 105 drugs
| Novolog Flexpen | 94 | $71,000 | $755 |
| Novolog | 71 | $69,549 | $980 |
| Lantus Solostar | 122 | $66,882 | $548 |
| Humalog Kwikpen U-100 | 61 | $47,761 | $783 |
| Victoza 3-Pak | 47 | $46,660 | $993 |
| Levemir Flextouch | 57 | $46,589 | $817 |
| Januvia | 50 | $35,587 | $712 |
| Humalog | 23 | $29,371 | $1,277 |
| Toujeo Solostar | 45 | $26,647 | $592 |
| Lantus | 40 | $24,430 | $611 |
| Tradjenta | 25 | $21,761 | $870 |
| Invokana | 34 | $18,540 | $545 |
| Humulin R U-500 Kwikpen | 11 | $18,455 | $1,678 |
| Victoza 2-Pak | 21 | $15,736 | $749 |
| Bydureon | 13 | $13,910 | $1,070 |
| Trulicity | 17 | $13,685 | $805 |
| Jardiance | 14 | $11,780 | $841 |
| Janumet | 16 | $10,044 | $628 |
| Levothyroxine | 363 | $8,718 | $24 |
| Farxiga | 11 | $7,985 | $726 |
| Symbicort | 27 | $7,951 | $294 |
| Combivent Respimat | 21 | $7,327 | $349 |
| Tanzeum | 12 | $7,229 | $602 |
| Androgel | 11 | $6,767 | $615 |
| Metformin Hcl Er | 114 | $6,187 | $54 |
| Dexilant | 22 | $5,656 | $257 |
| Ultra-Fine Nano Pen Needle | 66 | $5,097 | $77 |
| Spiriva | 11 | $4,051 | $368 |
| Rosuvastatin | 41 | $3,648 | $89 |
| Atorvastatin | 141 | $2,865 | $20 |
| Ultra-Fine Mini Pen Needle | 43 | $2,472 | $57 |
| Metformin | 241 | $2,055 | $9 |
| Liothyronine | 37 | $1,832 | $50 |
| Hydrocodone-Acetaminophen | 60 | $1,719 | $29 |
| Metoprolol | 39 | $1,631 | $42 |
| Gabapentin | 82 | $1,477 | $18 |
| Tamsulosin | 26 | $1,310 | $50 |
| Celecoxib | 12 | $1,291 | $108 |
| Amlodipine Besylate | 176 | $1,259 | $7 |
| Pravastatin | 26 | $1,163 | $45 |
| Ventolin Hfa | 19 | $1,108 | $58 |
| Novofine 32 | 20 | $1,064 | $53 |
| Lisinopril | 164 | $1,000 | $6 |
| Proair Hfa | 15 | $959 | $64 |
| Duloxetine | 19 | $950 | $50 |
| Bupropion Xl | 13 | $933 | $72 |
| Simvastatin | 104 | $933 | $9 |
| Losartan | 73 | $868 | $12 |
| Potassium Chloride | 36 | $867 | $24 |
| Venlafaxine Hcl Er | 27 | $769 | $28 |
| Nifedipine Er | 15 | $723 | $48 |
| Pioglitazone | 49 | $697 | $14 |
| Omeprazole | 50 | $651 | $13 |
| Tramadol | 34 | $635 | $19 |
| Methimazole | 40 | $615 | $15 |
| Venlafaxine | 11 | $571 | $52 |
| Insulin | 14 | $558 | $40 |
| Sumatriptan | 11 | $547 | $50 |
| Testosterone Cypionate | 13 | $534 | $41 |
| Hydrochlorothiazide | 75 | $529 | $7 |
| Phenobarbital | 14 | $514 | $37 |
| Promethazine | 15 | $509 | $34 |
| Oxybutynin Chloride | 16 | $480 | $30 |
| Alprazolam | 25 | $459 | $18 |
| Clopidogrel | 33 | $442 | $13 |
| Lisinopril-Hydrochlorothiazide | 42 | $409 | $10 |
| Cyclobenzaprine | 12 | $408 | $34 |
| Carvedilol | 42 | $387 | $9 |
| Pantoprazole | 44 | $381 | $9 |
| Trazodone | 53 | $363 | $7 |
| Ibuprofen | 24 | $350 | $15 |
| Fluticasone Propionate | 28 | $348 | $12 |
| Glipizide | 38 | $348 | $9 |
| Escitalopram | 14 | $329 | $24 |
| Spironolactone | 19 | $309 | $16 |
| Montelukast | 18 | $307 | $17 |
| Acyclovir | 19 | $304 | $16 |
| Hydroxyzine | 13 | $296 | $23 |
| Triamterene-Hydrochlorothiazid | 18 | $256 | $14 |
| Furosemide | 50 | $229 | $5 |
| Atenolol | 35 | $227 | $6 |
| Paroxetine | 25 | $221 | $9 |
| Topiramate | 21 | $216 | $10 |
| Ranitidine | 21 | $213 | $10 |
| Baclofen | 13 | $212 | $16 |
| Zolpidem | 40 | $203 | $5 |
| Ropinirole | 13 | $197 | $15 |
| Citalopram Hbr | 13 | $171 | $13 |
| Ondansetron | 11 | $169 | $15 |
| Allopurinol | 13 | $167 | $13 |
| Alendronate | 14 | $158 | $11 |
| Nortriptyline | 11 | $144 | $13 |
| Estradiol | 16 | $134 | $8 |
| Fluoxetine | 20 | $127 | $6 |
| Ciprofloxacin | 22 | $123 | $6 |
| Ibu | 12 | $118 | $10 |
| Benazepril | 15 | $117 | $8 |
| Amoxicillin | 20 | $116 | $6 |
| Lorazepam | 31 | $113 | $4 |
| Clonazepam | 14 | $92 | $7 |
| Famotidine | 13 | $86 | $7 |
| Finasteride | 11 | $73 | $7 |
| Terazosin | 11 | $73 | $7 |
| Metoprolol | 17 | $69 | $4 |
| Meloxicam | 11 | $54 | $5 |
2016: 100 drugs
| Lantus Solostar | 97 | $51,758 | $534 |
| Humalog | 38 | $47,800 | $1,258 |
| Novolog Flexpen | 77 | $44,288 | $575 |
| Novolog | 62 | $38,996 | $629 |
| Levemir Flextouch | 72 | $37,719 | $524 |
| Januvia | 53 | $34,357 | $648 |
| Lantus | 52 | $31,871 | $613 |
| Victoza 3-Pak | 43 | $30,810 | $717 |
| Humalog Kwikpen U-100 | 37 | $28,823 | $779 |
| Tradjenta | 37 | $23,012 | $622 |
| Bydureon | 13 | $16,697 | $1,284 |
| Victoza 2-Pak | 17 | $13,959 | $821 |
| Invokana | 16 | $10,895 | $681 |
| Farxiga | 16 | $10,461 | $654 |
| Toujeo Solostar | 19 | $10,294 | $542 |
| Tanzeum | 13 | $9,227 | $710 |
| Levothyroxine | 331 | $7,755 | $23 |
| Bd Ultra-Fine Pen Needle | 125 | $7,648 | $61 |
| Apidra Solostar | 15 | $7,058 | $471 |
| Humalog Mix 75-25 Kwikpen | 13 | $6,164 | $474 |
| Dexilant | 25 | $5,989 | $240 |
| Benicar | 14 | $5,144 | $367 |
| Combivent Respimat | 12 | $3,883 | $324 |
| Bromocriptine Mesylate | 14 | $2,886 | $206 |
| Hydrocodone-Acetaminophen | 60 | $2,467 | $41 |
| Metformin | 206 | $1,940 | $9 |
| Atorvastatin | 101 | $1,924 | $19 |
| Gabapentin | 68 | $1,915 | $28 |
| Metoprolol | 27 | $1,536 | $57 |
| Pravastatin | 40 | $1,478 | $37 |
| Colestipol | 11 | $1,451 | $132 |
| Novofine 32 | 27 | $1,354 | $50 |
| Lisinopril | 153 | $1,337 | $9 |
| Tamsulosin | 22 | $1,301 | $59 |
| Dilantin | 11 | $1,241 | $113 |
| Amlodipine Besylate | 161 | $1,209 | $8 |
| Synthroid | 26 | $1,125 | $43 |
| Duloxetine | 23 | $977 | $42 |
| Liothyronine | 28 | $943 | $34 |
| Estradiol | 15 | $919 | $61 |
| Metformin Hcl Er | 79 | $910 | $12 |
| Testosterone Cypionate | 11 | $892 | $81 |
| Proair Hfa | 13 | $804 | $62 |
| Betamethasone Dipropionate | 11 | $768 | $70 |
| Rosuvastatin | 12 | $767 | $64 |
| Bupropion Xl | 15 | $763 | $51 |
| Ondansetron | 23 | $749 | $33 |
| Simvastatin | 63 | $718 | $11 |
| Digoxin | 13 | $712 | $55 |
| Pantoprazole | 36 | $698 | $19 |
| Insulin | 14 | $666 | $48 |
| Losartan | 53 | $645 | $12 |
| Enalapril Maleate | 11 | $612 | $56 |
| Omeprazole | 45 | $595 | $13 |
| Potassium Chloride | 20 | $585 | $29 |
| Methimazole | 41 | $571 | $14 |
| Valsartan | 12 | $568 | $47 |
| Nifedical Xl | 14 | $475 | $34 |
| Tramadol | 30 | $448 | $15 |
| Trazodone | 35 | $421 | $12 |
| Hydrochlorothiazide | 75 | $419 | $6 |
| Ibuprofen | 26 | $406 | $16 |
| Fluticasone Propionate | 34 | $389 | $11 |
| Venlafaxine | 16 | $376 | $23 |
| Lovastatin | 11 | $374 | $34 |
| Clopidogrel | 22 | $353 | $16 |
| Paroxetine | 40 | $353 | $9 |
| Triamterene-Hydrochlorothiazid | 26 | $352 | $14 |
| Baclofen | 14 | $327 | $23 |
| Carvedilol | 36 | $326 | $9 |
| Pioglitazone | 27 | $298 | $11 |
| Alprazolam | 20 | $287 | $14 |
| Acyclovir | 18 | $259 | $14 |
| Furosemide | 57 | $250 | $4 |
| Topiramate | 21 | $249 | $12 |
| Venlafaxine Hcl Er | 11 | $247 | $22 |
| Glipizide | 16 | $241 | $15 |
| Famotidine | 12 | $229 | $19 |
| Prednisone | 13 | $229 | $18 |
| Clonazepam | 20 | $216 | $11 |
| Fluconazole | 13 | $215 | $17 |
| Spironolactone | 14 | $192 | $14 |
| Alendronate | 21 | $186 | $9 |
| Montelukast | 11 | $178 | $16 |
| Atenolol | 27 | $177 | $7 |
| Ranitidine | 18 | $173 | $10 |
| Lisinopril-Hydrochlorothiazide | 20 | $166 | $8 |
| Escitalopram | 11 | $162 | $15 |
| Sulfamethoxazole-Trimethoprim | 16 | $153 | $10 |
| Benazepril | 14 | $146 | $10 |
| Ciprofloxacin | 34 | $143 | $4 |
| Sumatriptan | 13 | $139 | $11 |
| Ropinirole | 14 | $129 | $9 |
| Lorazepam | 32 | $118 | $4 |
| Clonidine | 23 | $115 | $5 |
| Fluoxetine | 14 | $111 | $8 |
| Zolpidem | 24 | $95 | $4 |
| Nortriptyline | 12 | $88 | $7 |
| Amoxicillin | 14 | $63 | $5 |
| Metoprolol | 20 | $51 | $3 |
2015: 84 drugs
| Lantus Solostar | 106 | $61,646 | $582 |
| Lantus | 50 | $40,342 | $807 |
| Novolog Flexpen | 55 | $34,613 | $629 |
| Novolog | 45 | $24,963 | $555 |
| Januvia | 36 | $22,439 | $623 |
| Levemir Flextouch | 46 | $20,861 | $453 |
| Humalog Kwikpen U-100 | 25 | $11,774 | $471 |
| Apidra Solostar | 20 | $10,526 | $526 |
| Humalog Mix 75-25 Kwikpen | 21 | $10,207 | $486 |
| Tradjenta | 12 | $8,368 | $697 |
| Humalog | 25 | $7,722 | $309 |
| Levothyroxine | 286 | $7,393 | $26 |
| Metformin Hcl Er | 52 | $6,991 | $134 |
| Crestor | 16 | $5,864 | $367 |
| Invokana | 12 | $5,768 | $481 |
| Symbicort | 15 | $4,613 | $308 |
| Dexilant | 16 | $4,282 | $268 |
| Jentadueto | 11 | $3,800 | $345 |
| Bd Ultra-Fine Pen Needle | 69 | $3,707 | $54 |
| Benicar | 12 | $3,248 | $271 |
| Proair Hfa | 28 | $2,769 | $99 |
| Gabapentin | 62 | $2,117 | $34 |
| Atorvastatin | 72 | $2,047 | $28 |
| Metoprolol | 33 | $1,808 | $55 |
| Bumetanide | 22 | $1,676 | $76 |
| Estradiol | 12 | $1,545 | $129 |
| Hydrocodone-Acetaminophen | 43 | $1,510 | $35 |
| Novofine 32 | 29 | $1,286 | $44 |
| Alprazolam Odt | 12 | $1,230 | $102 |
| Cabergoline | 15 | $1,147 | $76 |
| Tamsulosin | 21 | $1,079 | $51 |
| Bromocriptine Mesylate | 12 | $1,049 | $87 |
| Amlodipine Besylate | 131 | $1,015 | $8 |
| Liothyronine | 18 | $939 | $52 |
| Metformin | 114 | $935 | $8 |
| Duloxetine | 19 | $925 | $49 |
| Omeprazole | 68 | $904 | $13 |
| Insulin | 24 | $882 | $37 |
| Synthroid | 20 | $861 | $43 |
| Enalapril Maleate | 15 | $856 | $57 |
| Doxycycline Hyclate | 19 | $758 | $40 |
| Bupropion Xl | 15 | $711 | $47 |
| Butalbital-Acetaminophen-Caffe | 12 | $701 | $58 |
| Zolpidem | 29 | $700 | $24 |
| Lisinopril | 104 | $698 | $7 |
| Hydrocortisone | 18 | $663 | $37 |
| Losartan | 57 | $635 | $11 |
| Pravastatin | 14 | $608 | $43 |
| Simvastatin | 52 | $553 | $11 |
| Oxybutynin Chloride | 11 | $526 | $48 |
| Methimazole | 36 | $511 | $14 |
| Pantoprazole | 27 | $406 | $15 |
| Promethazine | 11 | $406 | $37 |
| Lorazepam | 56 | $406 | $7 |
| Paroxetine | 38 | $387 | $10 |
| Hydrochlorothiazide | 80 | $375 | $5 |
| Tramadol | 38 | $371 | $10 |
| Clopidogrel | 18 | $355 | $20 |
| Insulin | 12 | $328 | $27 |
| Topiramate | 13 | $321 | $25 |
| Fluoxetine | 24 | $305 | $13 |
| Spironolactone | 15 | $275 | $18 |
| Acyclovir | 21 | $272 | $13 |
| Alprazolam | 39 | $260 | $7 |
| Ranitidine | 12 | $258 | $22 |
| Trazodone | 28 | $237 | $8 |
| Glipizide | 23 | $233 | $10 |
| Fluticasone Propionate | 25 | $221 | $9 |
| Ropinirole | 15 | $203 | $14 |
| Pioglitazone | 17 | $189 | $11 |
| Escitalopram | 12 | $179 | $15 |
| Furosemide | 48 | $178 | $4 |
| Hydromorphone | 12 | $138 | $11 |
| Baclofen | 19 | $136 | $7 |
| Atenolol | 19 | $122 | $6 |
| Clotrimazole | 11 | $122 | $11 |
| Nortriptyline | 12 | $114 | $9 |
| Ciprofloxacin | 27 | $98 | $4 |
| Ibuprofen | 13 | $97 | $7 |
| Allopurinol | 11 | $89 | $8 |
| Cephalexin | 13 | $77 | $6 |
| Sulfamethoxazole-Trimethoprim | 13 | $62 | $5 |
| Clonidine | 14 | $43 | $3 |
| Metoprolol | 11 | $43 | $4 |
2014: 65 drugs
| Lantus Solostar | 64 | $36,518 | $571 |
| Lantus | 51 | $29,262 | $574 |
| Novolog Flexpen | 46 | $23,619 | $513 |
| Levemir Flexpen | 33 | $17,797 | $539 |
| Novolog | 24 | $15,530 | $647 |
| Januvia | 32 | $12,044 | $376 |
| Humalog | 21 | $11,376 | $542 |
| Apidra Solostar | 14 | $9,059 | $647 |
| Crestor | 24 | $6,656 | $277 |
| Janumet Xr | 13 | $6,396 | $492 |
| Levothyroxine | 236 | $4,910 | $21 |
| Tradjenta | 11 | $3,814 | $347 |
| Dexilant | 13 | $2,836 | $218 |
| Bd Ultra-Fine Pen Needle | 41 | $2,620 | $64 |
| Humulin N | 25 | $2,281 | $91 |
| Metformin Hcl Er | 25 | $1,866 | $75 |
| Metformin | 117 | $1,585 | $14 |
| Novofine 32 | 30 | $1,298 | $43 |
| Atorvastatin | 43 | $1,296 | $30 |
| Metoprolol | 29 | $1,217 | $42 |
| Synthroid | 36 | $1,181 | $33 |
| Venlafaxine Hcl Er | 12 | $1,027 | $86 |
| Insulin | 20 | $955 | $48 |
| Bromocriptine Mesylate | 14 | $954 | $68 |
| Hydrocodone-Acetaminophen | 42 | $951 | $23 |
| Liothyronine | 29 | $923 | $32 |
| Insulin | 19 | $894 | $47 |
| Lisinopril | 90 | $879 | $10 |
| Omeprazole | 68 | $816 | $12 |
| Insulin | 16 | $790 | $49 |
| Hydralazine | 25 | $744 | $30 |
| Proair Hfa | 14 | $732 | $52 |
| Amlodipine Besylate | 71 | $709 | $10 |
| Losartan | 45 | $661 | $15 |
| Hydrocortisone | 21 | $639 | $30 |
| Oxybutynin Chloride | 14 | $523 | $37 |
| Simvastatin | 38 | $515 | $14 |
| Gabapentin | 26 | $473 | $18 |
| Methimazole | 30 | $470 | $16 |
| Doxazosin Mesylate | 13 | $452 | $35 |
| Glipizide | 25 | $349 | $14 |
| Fluticasone Propionate | 19 | $330 | $17 |
| Alprazolam | 41 | $306 | $7 |
| Hydrochlorothiazide | 60 | $304 | $5 |
| Lovastatin | 19 | $292 | $15 |
| Klor-Con M10 | 11 | $285 | $26 |
| Paroxetine | 25 | $285 | $11 |
| Tramadol | 29 | $279 | $10 |
| Fluoxetine | 23 | $269 | $12 |
| Lorazepam | 36 | $260 | $7 |
| Diphenoxylate-Atropine | 12 | $249 | $21 |
| Triamterene-Hydrochlorothiazid | 12 | $246 | $21 |
| Tamsulosin | 11 | $205 | $19 |
| Furosemide | 45 | $195 | $4 |
| Atenolol | 29 | $189 | $7 |
| Metoprolol | 15 | $128 | $9 |
| Risperidone | 12 | $127 | $11 |
| Allopurinol | 16 | $125 | $8 |
| Trazodone | 16 | $122 | $8 |
| Azithromycin | 13 | $104 | $8 |
| Ranitidine | 14 | $99 | $7 |
| Zolpidem | 14 | $93 | $7 |
| Ciprofloxacin | 14 | $77 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $58 | $5 |
| Amoxicillin | 11 | $47 | $4 |
2013: 42 drugs
| Lantus | 46 | $25,340 | $551 |
| Humalog | 26 | $23,020 | $885 |
| Lantus Solostar | 29 | $9,272 | $320 |
| Novolog | 17 | $9,132 | $537 |
| Janumet Xr | 15 | $5,815 | $388 |
| Novolog Flexpen | 18 | $5,687 | $316 |
| Humulin N | 50 | $4,757 | $95 |
| Levemir Flexpen | 16 | $4,522 | $283 |
| Januvia | 12 | $4,112 | $343 |
| Levothyroxine | 171 | $1,993 | $12 |
| Crestor | 11 | $1,936 | $176 |
| Dexilant | 11 | $1,752 | $159 |
| Atorvastatin | 29 | $1,652 | $57 |
| Humulin R | 19 | $1,642 | $86 |
| Metformin | 131 | $1,558 | $12 |
| Methimazole | 45 | $1,535 | $34 |
| Bd Ultra-Fine Pen Needle | 32 | $1,404 | $44 |
| Insulin | 30 | $1,383 | $46 |
| Insulin | 31 | $1,193 | $38 |
| Insulin | 27 | $1,032 | $38 |
| Hydrocortisone | 18 | $1,004 | $56 |
| Glipizide | 41 | $850 | $21 |
| Novofine 32 | 17 | $849 | $50 |
| Bromocriptine Mesylate | 11 | $736 | $67 |
| Omeprazole | 44 | $650 | $15 |
| Liothyronine | 24 | $627 | $26 |
| Synthroid | 27 | $613 | $23 |
| Amlodipine Besylate | 40 | $376 | $9 |
| Lisinopril | 44 | $351 | $8 |
| Simvastatin | 30 | $349 | $12 |
| Lovastatin | 12 | $317 | $26 |
| Losartan | 15 | $229 | $15 |
| Hydrocodone-Acetaminophen | 23 | $206 | $9 |
| Alprazolam | 17 | $185 | $11 |
| Furosemide | 33 | $122 | $4 |
| Azithromycin | 12 | $112 | $9 |
| Pantoprazole | 12 | $90 | $7 |
| Zolpidem | 15 | $88 | $6 |
| Atenolol | 17 | $82 | $5 |
| Hydrochlorothiazide | 14 | $68 | $5 |
| Ciprofloxacin | 14 | $65 | $5 |
| Amitriptyline | 12 | $30 | $3 |
Money from drug and device companies
$2,600 in 2025
| 2025 | 37 | 118 | None | $2,600 |
| 2024 | 25 | 112 | None | $2,314 |
| 2023 | 28 | 107 | None | $2,212 |
| 2022 | 27 | 107 | None | $2,020 |
| 2021 | 29 | 93 | None | $1,972 |
| 2020 | 22 | 50 | None | $1,348 |
| 2019 | 23 | 133 | None | $2,367 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Tepezza | $268 | 16 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $182 | 6 payments
|
| Novo Nordisk | Wegovy | $160 | 8 payments
|
| Lilly USA | Mounjaro | $159 | 9 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $147 | 8 payments
|
| Recordati Rare Diseases Inc. | Isturisa | $145 | 5 payments
|
See all 118 published payments
| Madrigal Pharmaceuticals | Meals · 2025-12-18 | Rezdiffra | $28 |
| Amgen | Meals · 2025-12-16 | Evenity | $33 |
| Beta Bionics | Meals · 2025-12-16 | Ilet Bionic Pancreas | $21 |
| Xeris Pharmaceuticals | Meals · 2025-12-15 | Recorlev | $24 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-12 | Kerendia | $14 |
| Xeris Pharmaceuticals | Meals · 2025-12-12 | Gvoke Hypopen | $24 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-10 | Jardiance | $27 |
| Amphastar Pharmaceuticals | Meals · 2025-12-10 | None | $22 |
| Amgen | Meals · 2025-12-10 | Evenity | $14 |
| Intra-Sana Laboratories | Meals · 2025-12-05 | Reltone 200 Mg | $29 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-04 | Jardiance | $27 |
| Fresenius Kabi USA | Meals · 2025-12-01 | None | $29 |
| GlaxoSmithKline | Meals · 2025-11-24 | Nucala | $22 |
| AGEPHA Pharma FZ | Meals · 2025-11-16 | Lodoco | $14 |
| Xeris Pharmaceuticals | Meals · 2025-11-11 | Recorlev | $16 |
| Lilly USA | Meals · 2025-11-09 | Jardiance | $26 |
| Amgen | Meals · 2025-11-07 | Tepezza | $29 |
| GlaxoSmithKline | Meals · 2025-11-06 | Shingrix | $18 |
| Novo Nordisk | Meals · 2025-11-05 | Wegovy | $24 |
| Exact Sciences | Meals · 2025-11-04 | None | $21 |
| Otsuka America Pharmaceutical | Meals · 2025-11-03 | Rexulti | $31 |
| Amgen | Meals · 2025-10-31 | Evenity | $3 |
| Rhythm Pharmaceuticals | Meals · 2025-10-31 | Imcivree | $26 |
| Lilly USA | Meals · 2025-10-30 | Mounjaro | $24 |
| Novartis Pharmaceuticals | Meals · 2025-10-22 | Rhapsido | $24 |
| Amgen | Meals · 2025-10-21 | Tepezza | $2 |
| Corcept Therapeutics | Meals · 2025-10-20 | Korlym | $25 |
| Madrigal Pharmaceuticals | Meals · 2025-10-16 | Rezdiffra | $34 |
| Lilly USA | Meals · 2025-10-15 | Mounjaro | $10 |
| Amgen | Meals · 2025-10-14 | Evenity | $5 |
| Intra-Sana Laboratories | Meals · 2025-10-13 | Reltone 200 Mg | $19 |
| Amgen | Meals · 2025-10-10 | Tepezza | $18 |
| Radius Health | Meals · 2025-10-07 | Tymlos | $23 |
| Genentech USA | Meals · 2025-09-30 | Xolair | $23 |
| Recordati Rare Diseases Inc. | Meals · 2025-09-29 | Isturisa | $30 |
| Sandoz | Meals · 2025-09-29 | Jubbonti | $15 |
| Novo Nordisk | Meals · 2025-09-26 | Wegovy | $6 |
| Optos | Entertainment · 2025-09-25 | Nfc-700 | $26 |
| Xeris Pharmaceuticals | Meals · 2025-09-23 | Gvoke Hypopen | $25 |
| Kyowa Kirin | Meals · 2025-09-19 | Crysvita | $28 |
| Almatica Pharma | Meals · 2025-09-18 | Teriparatide | $24 |
| Beta Bionics | Meals · 2025-09-17 | Ilet Bionic Pancreas | $21 |
| Seqirus USA | Meals · 2025-09-16 | Flucelvax | $16 |
| Cipher Pharmaceuticals US | Meals · 2025-09-12 | Natroba | $22 |
| Mannkind | Meals · 2025-09-11 | Afrezza | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-10 | Kerendia | $12 |
| Lilly USA | Meals · 2025-09-08 | Mounjaro | $12 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-04 | Jardiance | $31 |
| Madrigal Pharmaceuticals | Meals · 2025-08-29 | Rezdiffra | $29 |
| Novo Nordisk | Meals · 2025-08-22 | Rybelsus | $25 |
| Sanofi-Aventis U.S. | Meals · 2025-08-21 | Tzield | $19 |
| Madrigal Pharmaceuticals | Meals · 2025-08-20 | Rezdiffra | $28 |
| Exact Sciences | Meals · 2025-08-18 | None | $21 |
| Sequel Med Tech | Meals · 2025-08-15 | Twiist | $23 |
| Lilly USA | Meals · 2025-08-08 | Mounjaro | $14 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-07 | Jardiance | $29 |
| GlaxoSmithKline | Meals · 2025-08-01 | Shingrix | $23 |
| Amgen | Meals · 2025-08-01 | Evenity | $27 |
| Madrigal Pharmaceuticals | Meals · 2025-07-31 | Rezdiffra | $27 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-30 | Kerendia | $21 |
| Amgen | Meals · 2025-07-29 | Tepezza | $31 |
| Lilly USA | Meals · 2025-07-15 | Zepbound | $10 |
| Novartis Pharmaceuticals | Meals · 2025-07-10 | Leqvio | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-08 | Tezspire | $20 |
| Beta Bionics | Meals · 2025-07-07 | Ilet Bionic Pancreas | $28 |
| Lilly USA | Meals · 2025-07-04 | Jardiance | $21 |
| Recordati Rare Diseases Inc. | Meals · 2025-06-20 | Isturisa | $29 |
| Sanofi-Aventis U.S. | Meals · 2025-06-17 | Tzield | $25 |
| Abbott Laboratories | Meals · 2025-06-13 | Freestyle Libre 3 | $24 |
| Intra-Sana Laboratories | Meals · 2025-06-12 | Reltone 200 Mg | $26 |
| Intra-Sana Laboratories | Meals · 2025-06-05 | Reltone 200 Mg | $22 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-06-04 | Kerendia | $25 |
| Sandoz | Meals · 2025-06-03 | None | $30 |
| Amgen | Meals · 2025-06-03 | Repatha | $11 |
| Sanofi-Aventis U.S. | Meals · 2025-05-28 | Tzield | $15 |
| Amgen | Meals · 2025-05-27 | Repatha | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-05-17 | Dupixent | $29 |
| Madrigal Pharmaceuticals | Meals · 2025-05-15 | Rezdiffra | $35 |
| Amgen | Meals · 2025-05-14 | Tepezza | $18 |
| Novo Nordisk | Meals · 2025-05-09 | Wegovy | $18 |
| Novartis Pharmaceuticals | Meals · 2025-05-09 | Leqvio | $31 |
| Novo Nordisk | Meals · 2025-04-29 | Wegovy | $34 |
| Novo Nordisk | Meals · 2025-04-28 | Ozempic | $23 |
| Medtronic | Meals · 2025-04-24 | Inceptiv | $32 |
| Kyowa Kirin | Meals · 2025-04-15 | Crysvita | $30 |
| Intra-Sana Laboratories | Meals · 2025-04-03 | Reltone 200 Mg | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-02 | Tezspire | $21 |
| Medtronic | Meals · 2025-04-01 | Minimed 780g | $14 |
| Xeris Pharmaceuticals | Meals · 2025-03-28 | Gvoke Hypopen | $21 |
| Medtronic | Meals · 2025-03-27 | Inceptiv | $25 |
| Amgen | Meals · 2025-03-26 | Tepezza | $28 |
| Pfizer | Meals · 2025-03-21 | Prevnar 20 | $23 |
| Recordati Rare Diseases Inc. | Meals · 2025-03-19 | Isturisa | $28 |
| Recordati Rare Diseases Inc. | Meals · 2025-03-18 | Isturisa | $28 |
| Globus Medical | Meals · 2025-03-18 | Senza | $34 |
| Sanofi-Aventis U.S. | Meals · 2025-03-11 | Tzield | $27 |
| Beta Bionics | Meals · 2025-03-11 | Ilet Bionic Pancreas | $21 |
| Lilly USA | Meals · 2025-03-10 | Mounjaro | $18 |
| Novo Nordisk | Meals · 2025-03-08 | Wegovy | $8 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-07 | Jardiance | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-06 | Fasenra | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-06 | Kerendia | $31 |
| Amgen | Meals · 2025-03-06 | Tepezza | $5 |
| Exact Sciences | Meals · 2025-03-04 | Cologuard Collection Kit | $18 |
| Sanofi-Aventis U.S. | Meals · 2025-02-27 | Tzield | $31 |
| Amgen | Meals · 2025-02-24 | Evenity | $20 |
| Lilly USA | Meals · 2025-02-21 | Jardiance | $24 |
| Ascendis Pharma Endocrinology | Meals · 2025-02-19 | Yorvipath | $25 |
| Amgen | Meals · 2025-02-18 | Tepezza | $3 |
| Sanofi-Aventis U.S. | Meals · 2025-02-14 | Tzield | $14 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-13 | Kerendia | $19 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-13 | Kerendia | $2 |
| Novo Nordisk | Meals · 2025-02-11 | Ozempic | $22 |
| Recordati Rare Diseases Inc. | Meals · 2025-01-29 | Isturisa | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-27 | Tezspire | $19 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-24 | Kerendia | $24 |
| Pfizer | Meals · 2025-01-21 | Paxlovid | $23 |
| Beta Bionics | Meals · 2025-01-07 | Ilet Bionic Pancreas | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,314
| Lilly USA | Jardiance | $367 | 23 payments
|
| Amgen | Evenity | $331 | 15 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $191 | 10 payments
|
| Novartis Pharmaceuticals | Leqvio | $176 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $174 | 8 payments
|
| Mannkind | Afrezza | $141 | 7 payments
|
| Sanofi-Aventis U.S. | Tzield | $118 | 6 payments
|
| Novo Nordisk | Ozempic | $90 | 4 payments
|
| Beta Bionics | Ilet Bionic Pancreas | $83 | 3 payments
|
| Pfizer | Paxlovid | $80 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $69 | 3 payments
|
| Alexion Pharmaceuticals | Strensiq | $61 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $54 | 2 payments
|
| Insulet | Omnipod | $52 | 2 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $45 | 2 payments
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $42 | 2 payments
|
| Averitas Pharma | Qutenza | $36 | 1 payment
|
| Genzyme | Dupixent | $29 | 1 payment
|
| Recordati Rare Diseases Inc. | Signifor Lar | $29 | 1 payment
|
| Radius Health | Tymlos | $28 | 1 payment
|
| Axsome Therapeutics | Sunosi | $27 | 1 payment
|
| GlaxoSmithKline | Shingrix | $26 | 1 payment
|
| Greer Laboratories | Oralair | $23 | 1 payment
|
| Esperion Therapeutics | Nexletol | $23 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $21 | 1 payment
|
2023: $2,212
| Novo Nordisk | Rybelsus | $271 | 21 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $245 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $214 | 8 payments
|
| Lilly USA | Trulicity | $165 | 8 payments
|
| Novartis Pharmaceuticals | Leqvio | $159 | 8 payments
|
| Medtronic | Inpen Smart Insulin Delivery System | $146 | 5 payments
|
| GlaxoSmithKline | Arexvy | $135 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $121 | 6 payments
|
| Echosens North America | Fibroscan | $99 | 1 payment
|
| IBSA Pharma | Licart | $90 | 4 payments
|
| Alexion Pharmaceuticals | Strensiq | $64 | 3 payments
|
| MannKind | Afrezza | $62 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $54 | 2 payments
|
| Sanofi Pasteur | Fluzone Quadrivalent Northern Hemisphere | $41 | 2 payments
|
| Insulet | Omnipod | $37 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $34 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $33 | 2 payments
|
| Beta Bionics | Ilet Bionic Pancreas | $27 | 1 payment
|
| BioCryst US Sales Co. | Orladeyo | $26 | 1 payment
|
| Astellas Pharma US | Veozah | $26 | 1 payment
|
| Ascendis Pharma | None | $26 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $23 | 1 payment
|
| kaleo | Auvi-Q | $22 | 1 payment
|
| RGH Enterprises | None | $22 | 1 payment
|
| Genzyme | Dupixent | $20 | 1 payment
|
| Amgen | Repatha | $20 | 1 payment
|
| Currax Pharmaceuticals | Onzetra Xsail | $17 | 1 payment
|
| Pfizer | Prevnar 20 | $13 | 1 payment
|
2022: $2,020
| Novo Nordisk | Rybelsus | $236 | 17 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $226 | 11 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $165 | 7 payments
|
| Corcept Therapeutics | Korlym | $146 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $139 | 7 payments
|
| Amgen | Tezspire | $130 | 8 payments
|
| Horizon Therapeutics plc | Tepezza | $109 | 4 payments
|
| Lilly USA | Mounjaro | $89 | 4 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $76 | 3 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $72 | 4 payments
|
| Alexion Pharmaceuticals | Strensiq | $70 | 3 payments
|
| Abbvie | Ubrelvy | $61 | 3 payments
|
| GlaxoSmithKline | Shingrix | $58 | 2 payments
|
| Mannkind | Afrezza | $56 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $49 | 3 payments
|
| Radius Health | Tymlos | $49 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $44 | 2 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $39 | 2 payments
|
| Insulet | Omnipod | $34 | 2 payments
|
| Amryt Pharma Holdings | Mycapssa | $29 | 1 payment
|
| Medtronic | Inpen Smart Insulin Delivery System | $27 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $26 | 1 payment
|
| kaleo | Auvi-Q | $20 | 1 payment
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $20 | 1 payment
|
| CeQur | Cequr Simplicity | $19 | 1 payment
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $18 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 2 | $16 | 1 payment
|
2021: $1,972
| Novo Nordisk | Ozempic | $436 | 30 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $238 | 9 payments
|
| Merck Sharp & Dohme | Januvia | $97 | 5 payments
|
| Lilly USA | Trulicity | $95 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $87 | 5 payments
|
| Radius Health | Tymlos | $84 | 3 payments
|
| Medtronic | Minimed 770g System | $73 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $71 | 3 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $70 | 3 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $69 | 3 payments
|
| Amgen | Evenity | $64 | 2 payments
|
| GlaxoSmithKline | Anoro Ellipta | $59 | 2 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $58 | 3 payments
|
| MannKind | Afrezza | $58 | 3 payments
|
| Alexion Pharmaceuticals | Strensiq | $48 | 2 payments
|
| Teva Pharmaceuticals USA | Cinqair | $38 | 2 payments
|
| Zealand Pharma US | V-Go Disposable Insulin Delivery | $36 | 2 payments
|
| Genzyme | None | $35 | 1 payment
|
| Corcept Therapeutics | Korlym | $31 | 1 payment
|
| AbbVie | Synthroid | $30 | 1 payment
|
| Esperion Therapeutics | Nexletol | $28 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $27 | 1 payment
|
| Becton Dickinson and | Bd Nano | $26 | 1 payment
|
| OptiNose US | Xhance | $24 | 1 payment
|
| Clarus Therapeutics | Jatenzo | $22 | 1 payment
|
| kaleo | Auvi-Q | $19 | 1 payment
|
| IBSA Pharma | Tirosint | $19 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 2 | $17 | 1 payment
|
| Bigfoot Biomedical | Unity Diabetes Management System | $16 | 1 payment
|
2020: $1,348
| Amgen | Prolia | $263 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $261 | 7 payments
|
| Radius Health | Tymlos | $166 | 3 payments
|
| Lilly USA | Trulicity | $80 | 4 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $70 | 4 payments
|
| Abbott Laboratories | Freestyle Lite System | $69 | 2 payments
|
| Alexion Pharmaceuticals | Strensiq | $48 | 2 payments
|
| IBSA Pharma | Tirosint | $45 | 2 payments
|
| Medtronic MiniMed | Minimed 770g System | $43 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $39 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $37 | 2 payments
|
| Arbor Pharmaceuticals | Horizant | $34 | 2 payments
|
| Insulet | Omnipod | $31 | 2 payments
|
| Pfizer | Eucrisa | $26 | 2 payments
|
| Ferring Pharmaceuticals | Zomacton | $21 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $19 | 1 payment
|
| OptiNose US | Xhance | $18 | 1 payment
|
| iRhythm Technologies | Zio Patch | $17 | 1 payment
|
| Amarin Pharma | Vascepa | $16 | 1 payment
|
| Genentech USA | Xolair | $16 | 1 payment
|
| Novo Nordisk | Saxenda | $15 | 1 payment
|
| Corcept Therapeutics | Korlym | $14 | 1 payment
|
2019: $2,367
| Amgen | Evenity | $371 | 11 payments
|
| Novo Nordisk | Ozempic | $370 | 21 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $256 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $223 | 10 payments
|
| Lilly USA | Trulicity | $162 | 9 payments
|
| GlaxoSmithKline | Nucala | $125 | 11 payments
|
| Radius Health | Tymlos | $125 | 9 payments
|
| Mannkind | Afrezza | $96 | 5 payments
|
| AbbVie | Synthroid | $94 | 5 payments
|
| Companion Medical | Inpen | $75 | 5 payments
|
| Merck Sharp & Dohme | Januvia | $74 | 5 payments
|
| Nalpropion Pharmaceuticals | Contrave | $59 | 3 payments
|
| Corcept Therapeutics | Korlym | $57 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $54 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $48 | 3 payments
|
| Octapharma USA | Cutaquig | $38 | 1 payment
|
| IBSA Pharma | Tirosint | $32 | 2 payments
|
| Alexion Pharmaceuticals | Strensiq | $25 | 1 payment
|
| Shire North American Group | Natpara (Parathyroid Hormone) | $23 | 1 payment
|
| Janssen Pharmaceuticals | Invokana | $16 | 1 payment
|
| Abbott Laboratories | Freestyle Libre | $16 | 1 payment
|
| Kaleo | Auvi-Q | $15 | 1 payment
|
| Insulet | Omnipod | $14 | 1 payment
|
Professional record
- NPI
- 1902068562
- Licence
- CA A103188California A103188: Current · expires 2027-10-31
- Group
- Jiva Health Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
- Mailing address
- 2182 East St, Concord, CA, 94520
- NPI first listed
- 2008-06-25
- NPI last updated
- 2016-08-31
This is when the NPI record was last certified, not a medical board exam.